Cell MedX (Cell MedX) Total Assets : $0.08 Mil (As of Feb. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Cell MedX Total Assets?

Cell MedX's Total Assets for the quarter that ended in Feb. 2024 was $0.08 Mil.

During the past 12 months, Cell MedX's average Total Assets Growth Rate was -66.70% per year. During the past 3 years, the average Total Assets Growth Rate was -64.70% per year. During the past 5 years, the average Total Assets Growth Rate was -39.40% per year.

During the past 12 years, Cell MedX's highest 3-Year average Total Assets Growth Rate was -5.70%. The lowest was -64.70%. And the median was -19.15%.

Total Assets is connected with ROA %. Cell MedX's annualized ROA % for the quarter that ended in Feb. 2024 was 914.29%. Total Assets is also linked to Revenue through Asset Turnover. Cell MedX's Asset Turnover for the quarter that ended in Feb. 2024 was 0.00.

Cell MedX Total Assets Historical Data

The historical data trend for Cell MedX's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cell MedX Total Assets Chart

Cell MedX Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

Total Assets

Get a 7-Day Free Trial

0.19

0.16

0.05

0.04

0.10

Cell MedX Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Total Assets	Get a 7-Day Free Trial															0.01	0.10	0.06	0.02	0.08

Cell MedX Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Cell MedX's Total Assets for the fiscal year that ended in May. 2023 is calculated as

Total Assets	=	Total Equity (A: May. 2023 )	+	Total Liabilities (A: May. 2023 )
	=	-2.385	+	2.489
	=	0.10

Cell MedX's Total Assets for the quarter that ended in Feb. 2024 is calculated as

Total Assets	=	Total Equity (Q: Feb. 2024 )	+	Total Liabilities (Q: Feb. 2024 )
	=	-0.71	+	0.792
	=	0.08

Cell MedX (OTCPK:CMXC) Total Assets Explanation

Total Assets is connected with ROA %.

Cell MedX's annualized ROA % for the quarter that ended in Feb. 2024 is

ROA %	=	Net Income (Q: Feb. 2024 )	/	( (Total Assets (Q: Nov. 2023 )	+	Total Assets (Q: Feb. 2024 ))	/ count )
	=	0.48	/	( (0.023	+	0.082)	/ 2 )
	=	0.48	/	0.0525
	=	914.29 %

Note: The Net Income data used here is four times the quarterly (Feb. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Cell MedX's Asset Turnover for the quarter that ended in Feb. 2024 is

	Asset Turnover
=	Revenue (Q: Feb. 2024 )	/	( (Total Assets (Q: Nov. 2023 )	+	Total Assets (Q: Feb. 2024 ))	/ count )
=	0	/	( (0.023	+	0.082)	/ 2 )
=	0	/	0.0525
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Cell MedX Total Assets Related Terms

Thank you for viewing the detailed overview of Cell MedX's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Cell MedX (Cell MedX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cell MedX Corp (OTCPK:CMXC) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

123 W. Nye Lane, Suite 446, Carson City, NV, USA, 89706

Website

https://www.cellmedx.com

Cell MedX Corp is an early stage development company focused on the discovery, development and, commercialization of therapeutic products for patients with diseases such as diabetes, by developing technologies to help manage the illness and related complications. The company's product portfolio consists of electromedical technologies, ebalance, and others.

Executives

Richard Jeffs	10 percent owner	FLAT 7, 6 ENNISMORE GARDENS, LONDON X0 SW7 1NL
Dwayne Yaretz	director, officer: Chief Executive Officer	SUITE 1050 WEST PENDER STREET SUITE 2250, VANCOUVER A1 V6E 3S7
Bradley S Hargreaves	10 percent owner	904-1616 BAYSHORE DR, VANCOUVER A1 V6G3L1
Frank Mcenulty	director, officer: CEO, CFO, Treas., Sec	4182 N. VIKING WAY, SUITE 216, LONG BEACH CA 90808-1475
Joao Dacosta	director, officer: COO	#810 - 789 WEST PENDER STREET, VANCOUVER A1 V6C 1H2
George Adams	director	7535 CONSERVATION ROAD, GUELPH A6 N1H6J1
Terrance George Owen	director, officer: CEO	635 FOURTH LINE (UNIT 1), OAKVILLE A6 L6L 5BO
John David Sanderson	officer: Chief Medical Officer	9 ISLANDVIEW, IRVINE CA 92604
Yanika S Silina	officer: CFO, Treasurer and Secretary	789 WEST PENDER STREET, UNIT 810, VANCOUVER A1 V6C 1H2
Jean M Arnett	10 percent owner	121 - 3989 HENNING DRIVE, BURNABY A1 V5C 6P8
Ean Kremer	director, officer: Chief Technology Officer	C/O PLANDEL RESOURCES, INC., 4575 DEAN MARTIN DRIVE, STE. 2206, LAS VEGAS NV 89103

Cell MedX (Cell MedX) Headlines

From GuruFocus

Cell MedX Insider Buys 22,500 Shares

By Kyle Ferguson Kyle Ferguson • 11-11-2016